Choline Fenofibrate Delayed Release Capsules Versus Conventional Fenofibrate Tablets for Dyslipidemia: A Randomized, Non-Inferiority Trial

J Assoc Physicians India. 2015 Aug;63(8):20-6.

Authors

Manish Agarwal¹, Veer Bahadur Singh², Praveen Garg³, Puneet Rijhwani⁴, Navneet Agrawal⁵, Sandeep Tak⁶, Ravindra Mittal⁷, Pavankumar Daultani⁸, Prafulla Pawar⁹

Affiliations

¹ Consultant Physician, Medilink Hospital and Research Centre.
² Professor, Department of Medicine, SP Medical College and AG Hospitals, Bikaner, Rajasthan.
³ Consultant Physician, Shashwat Hospital and Research Centre.
⁴ Consultant Physician, K2 Clinic, Jaipur, Rajasthan.
⁵ Consultant Physician, Diabetes, Obesity and Thyroid Centre, Gwalior, Madhya Pradesh.
⁶ Consultant Physician, Jodhpur, Rajasthan.
⁷ Senior Vice President.
⁸ Manager.
⁹ Dy. Manager, Cadila Healthcare Limited, Ahmedabad, Gujarat.

PMID: 27604432

No abstract available

Publication types

Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Biological Availability
Capsules
Choline / administration & dosage
Choline / adverse effects
Choline / analogs & derivatives*
Choline / pharmacokinetics
Delayed-Action Preparations / administration & dosage
Delayed-Action Preparations / adverse effects
Delayed-Action Preparations / pharmacokinetics
Drug Monitoring / methods
Female
Fenofibrate* / administration & dosage
Fenofibrate* / adverse effects
Fenofibrate* / pharmacokinetics
Humans
Hypertriglyceridemia / diagnosis
Hypertriglyceridemia / drug therapy*
Hypolipidemic Agents / administration & dosage
Hypolipidemic Agents / adverse effects
Hypolipidemic Agents / pharmacokinetics
Male
Middle Aged
Tablets
Treatment Outcome

Substances

Capsules
Delayed-Action Preparations
Hypolipidemic Agents
Tablets
choline fibrate
Choline
Fenofibrate